Monoclonal Antibodies in Neurology: Current State and Future Development

Monoclonal antibodies are one of the fastest growing areas of specific therapy for cancer, infectious, autoimmune, and demyelinating diseases. The main targets of monoclonal antibodies in autoimmune and demyelinating diseases are T and B lymphocytes, cytokines, complement, and adhesion molecules. In...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human physiology Jg. 48; H. 8; S. 932 - 937
1. Verfasser:	Zakharova, M. N.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Moscow Pleiades Publishing 01.12.2022 Springer Nature B.V
Schlagworte:	Alzheimer's disease Autoimmune diseases Biomedical and Life Sciences Biomedicine CD19 antigen CD20 antigen Demyelinating diseases Demyelination Human Physiology Life Sciences Lymphocytes B Monoclonal antibodies Multiple sclerosis Nanobodies Neurodegenerative diseases Neuromyelitis Parenchyma β-Amyloid nanobodies Alzheimer’s disease demyelinating diseases multiple sclerosis neuromyelitis optica monoclonal antibodies
ISSN:	0362-1197, 1608-3164
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!